Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

45
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
45
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

44
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
44
Drug Therapy01:28

Drug Therapy

131
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
131
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

80
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
80
Standards of Care II01:19

Standards of Care II

851
Nurses bear specific legal responsibilities under several federal statutes, including:
851
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

62
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distal interphalangeal joint capsule enthesopathy of the middle phalanx and articular cartilage loss.

Equine veterinary journal·2025
Same author

Metabolic heterogeneity exists across equine distal limb tendons and ligaments in healthy, metabolically normal horses.

American journal of veterinary research·2025
Same author

Western performance horses with fetlock lameness demonstrate radiographic evidence of chronic exercise remodelling.

Equine veterinary journal·2025
Same author

Severity, distribution and postoperative therapy are not predictors of return to work in western performance horses with stifle chondromalacia.

Veterinary surgery : VS·2025
Same author

Acute tear versus chronic-degenerated rotator cuff pathologies are associated with divergent tendon metabolite profiles.

Connective tissue research·2024
Same author

Blood flow restriction training does not negatively alter the mechanical strength or histomorphology of uninjured equine superficial digital flexor tendons.

Equine veterinary journal·2024

Related Experiment Video

Updated: Nov 1, 2025

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy
07:52

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

Published on: December 9, 2015

10.0K

Current joint therapy usage in equine practice: Changes in the last 10 years.

Gustavo M Zanotto1, David D Frisbie2

  • 1Department of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.

Equine Veterinary Journal
|June 18, 2021
PubMed
Summary

Veterinary use of joint therapies in horses has shifted, with decreased use of methylprednisolone acetate in high-motion joints and increased adoption of biological therapies like autologous conditioned serum.

Keywords:
articular treatmentbiological therapiescorticosteroidhorseosteoarthritis

More Related Videos

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis
04:23

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis

Published on: August 25, 2023

1.7K
Construction of a Realistic, Whole-Body, Three-Dimensional Equine Skeletal Model using Computed Tomography Data
11:09

Construction of a Realistic, Whole-Body, Three-Dimensional Equine Skeletal Model using Computed Tomography Data

Published on: February 25, 2021

3.5K

Related Experiment Videos

Last Updated: Nov 1, 2025

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy
07:52

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

Published on: December 9, 2015

10.0K
Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis
04:23

Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis

Published on: August 25, 2023

1.7K
Construction of a Realistic, Whole-Body, Three-Dimensional Equine Skeletal Model using Computed Tomography Data
11:09

Construction of a Realistic, Whole-Body, Three-Dimensional Equine Skeletal Model using Computed Tomography Data

Published on: February 25, 2021

3.5K

Area of Science:

  • Equine medicine
  • Veterinary pharmacology
  • Joint disease management

Background:

  • Osteoarthritis is a prevalent condition in performance horses.
  • Significant advancements in understanding and treating equine osteoarthritis have occurred in the past decade.

Purpose of the Study:

  • To track changes in the clinical application of joint therapies over the last 10 years.
  • To assess the integration of newly developed therapies into equine veterinary practice.

Main Methods:

  • An electronic survey was distributed to members of the American Association of the Equine Practitioners.
  • Survey questions from a 2009 study were repeated, with new questions added for the 2019 survey.
  • Responses were analyzed and compared to historical data.

Main Results:

  • Triamcinolone acetonide (TA) remains the preferred corticosteroid for high-motion joints, while methylprednisolone acetate (MPA) is favored for low-motion joints.
  • A notable decrease in MPA use for high-motion joints was observed between 2009 and 2019.
  • The utilization of biological therapies, such as autologous conditioned serum, significantly increased.
  • Concurrent administration of antibiotics with intra-articular medications became more common.

Conclusions:

  • Survey data reveals a shift in equine joint therapy practices over a decade.
  • While some trends align with scientific evidence, others diverge from or contradict the literature.
  • Practices show a decrease in MPA for high-motion joints and a rise in biological therapies.